Drug intelligence / Profile preview

ammonia + triamcinolone acetonide + lidocaine hydrochloride + povidone-iodine

Development stage
Unknown
Lead developer
Asclemed USA
Modality
Small Molecules
Administration
Intramuscular, Intraarticular, Injection, Topical
01

Overview

A multi-component pharmaceutical kit combining **triamcinolone acetonide**, a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive activity; **lidocaine hydrochloride**, a local anesthetic used to provide procedural analgesia; **povidone-iodine**, a topical antiseptic used for skin preparation; and **ammonia**, included as a kit component. In the cited context this combination corresponds to the **Physician EZ Use Joint Tunnel and Trigger Kit**, an unapproved combination product distributed for office-based joint, tunnel, and trigger-point procedures. The pharmacologically central therapeutic component is triamcinolone acetonide, which exerts clinical effects primarily through glucocorticoid receptor agonism for inflammatory and autoimmune conditions and by intra-articular or soft-tissue injection for disorders such as rheumatoid arthritis, bursitis, epicondylitis, tenosynovitis, synovitis of osteoarthritis, and acute gouty arthritis; lidocaine provides local anesthesia and povidone-iodine supports antisepsis.

Brand names
Physician EZ Use Joint Tunnel and Trigger Kit
Other names
ammonia + triamcinolone acetonide + lidocaine hydrochloride + povidone-iodinejoint tunnel and trigger kit
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on ammonia + triamcinolone acetonide + lidocaine hydrochloride + povidone-iodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ammonia + triamcinolone acetonide + lidocaine hydrochloride + povidone-iodine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call